Copyright
©The Author(s) 2023.
World J Gastrointest Oncol. Feb 15, 2023; 15(2): 225-239
Published online Feb 15, 2023. doi: 10.4251/wjgo.v15.i2.225
Published online Feb 15, 2023. doi: 10.4251/wjgo.v15.i2.225
Target | Ferroptosis inducers | Ref. |
ACSL4 | Bromelain | [35] |
Apatinib | [37] | |
Emodin | [36] | |
SLC7A11 | Erastin | [42] |
SAS | [44,45] | |
Talaroconvolutin A | [50] | |
Copper chelator elesclomol | [51] | |
IMCA | [52] | |
Pt3R5G | [53] | |
RSV | [54] | |
Transsulfuration pathway | CARS | [65] |
VZnO | [66] | |
GPX4 | Erastin | [67] |
RSL3 | [67] | |
ACADSB | [79] | |
Nrf2/HO-1 | Cetuximab | [87] |
Lys | [90] | |
Oxaliplatin | [94,95] | |
Cellular iron homeostasis | HIF-2α | [102] |
miR-545 | [104] | |
Dichloroacetate | [105] | |
IREB2 | [106] | |
P53 | Ginsenoside Rh4 | [113] |
Cullin-9 | [114] |
- Citation: Song YQ, Yan XD, Wang Y, Wang ZZ, Mao XL, Ye LP, Li SW. Role of ferroptosis in colorectal cancer. World J Gastrointest Oncol 2023; 15(2): 225-239
- URL: https://www.wjgnet.com/1948-5204/full/v15/i2/225.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v15.i2.225